[The efficacy of combined immunomodulatory therapy with timoptin and sodium nucleinate in patients with chronic obstructive bronchitis].
Study of the immunologic reactivity of 104 patients with chronic obstructive bronchitis revealed the deficiency of cellular immunity for the most part. The use of timoptin, sodium nucleinate and their combined application raised the clinical efficacy of the treatment of patients with chronic obstructive bronchitis, significantly reduced the concentration of medium-weight molecules in blood serum, and corrected immunity disorders.
Zemskov
A M
AM
Zemskov
V M
VM
Nikitin
A V
AV
Zazhireĭ
V D
VD
Evstratova
E F
EF
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D001772:Blood Cell Count; D001991:Bronchitis / Q000097:blood / Q000188:drug therapy*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006801:Humans; D008214:Lymphocytes / Q000276:immunology; D008875:Middle Aged; D009696:Nucleic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D012307:Risk Factors; D013951:Thymus Hormones / Q000008:administration & dosage / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D009696:Nucleic Acids; D013951:Thymus Hormones; C013683:sodium nucleinate
Effektivnost' kombinirovannoĭ immunomoduliruiushcheĭ terapii timoptinom i nukleinatom natriia u bol'nykh khronicheskim obstruktivnym bronkhitom.